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ABSTRACT 
The term bioadhesive describes materials that bind to biological substrates, such as mucosal membranes and in bioadhesive drug delivery 
systems, the term bioadhesion is used to describe the bonding or adhesion between a synthetic or natural polymer and soft tissues such as 
epithelial cells. The bioadhesive drug delivery formulation highlights the fact that readily accessible sites are utilized with the eye, oral cavity 
and vegina being targeted. The GI tract and the nasal cavity have also been extensively examined as a site for bioadhesive drug delivery. The 
term mucoadhesion is the subgroup of bioadhesion and in the mucoadhesion formulation attaches with the mucus membrane. The 
mucoadhesion can be defined as the adhesion between the two materials in which one is biological material and other one is polymeric 
materials with the help of interfacial forces to increase the residence time. Over the past few decades, mucosal drug delivery has received a 
great deal of attention. The mucoadhesion drug delivery system is better than the traditional drug delivery systems. Mucoadhesion is a useful 
strategy for drug delivery systems, such as tablets, patches, gels, liposomes, micro/nanoparticles, nanosuspensions, microemulsions and 
colloidal dispersions. The mucoadhesion bypasses the first pass metabolism and used for localized delivery of biomolecules such as peptides, 
proteins and oligonucleotides. Mucoadhesion drug delivery system engages much attention due to their benefits such as prolong retention time, 
fast uptake and increased bioavailability of active substance. Application of dosage forms to mucosal surfaces may be of benefit to drug 
molecules not amenable to the oral route, such as those that undergo acid degradation or extensive first-pass metabolism. The mucoadhesive 
ability of a dosage form is dependent upon a variety of factors, including the nature of the mucosal tissue and the physicochemical properties of 
the polymeric formulation. This review article aims to provide an overview of the various aspects of mucoadhesion, theories of mucoadhesion, 
mucoadhesive materials, factors affecting mucoadhesion, evaluating methods, mucoadhesive polymers and herbal drugs. 
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Introduction 
Since the early 1980s, the concept of mucoadhesion has 
gained considerable interest in pharmaceutical technology1. 
Adhesion can be defined as the bond produced by contact 
between a pressure -sensitive adhesive and a surface1. The 
American society of testing and materials has defined it as 
the state in which two surfaces are held together by 
interfacial forces, which may consist of valence forces, 
interlocking action or both2. The adhesion processes have 
demonstrated important purposes in nature and 
consequently, have diverse healthcare and non-biomedical 
implications, such as bacterial adhesion or water 
purification.  
In pharmaceutical sciences, bioadhesion is described as the 
ability of a dosage form to come into close contact, by 
attractive interactions with a biological surface (epithelial 
tissue or mucus coat). If the biological environment is the 
mucosal surface or mucous coat, this process is termed 
mucoadhesion3-6 . Bio-adhesion (or mucoadhesion) is 
generally understood to define the ability of a biological or 
synthetic material to “stick” to a mucous membrane, 
resulting in adhesion of the material to the tissue for a 
protracted period of time7. For a material to be bioadhesive, 
it must interact with mucus, which is a highly hydrated, 
viscous anionic hydrogel layer protecting the mucosa. The 
mucin is composed largely of flexible glycoprotein chains, 
which are crosslinked. Moreover, bio/mucoadhesion 
processes can be a useful approach with diverse advantages 
for drug delivery systems such as increased residence time at 
application sites, drug protection, increased drug permeation 
and improved drug availability8-10. Therefore, this strategy 
has been applied to several solid, semi-solid and liquid drug 
delivery systems, for example, buccal tablets, buccal patches 
or films, buccal gels for periodontitis treatment, ophthalmic 
liposomes, vaginal suppositories, as well as nano- or 
microparticles, nanosuspensions, microemulsions and 
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colloidal dispersions11. The formation of non-covalent bonds 
such as hydrogen bonds and ionic interactions or physical 
entanglements between the mucus gel layer and polymers 
provides a good mucoadhesion. In biological systems, four 
types of bio-adhesion could be distinguished  
• Adhesion of a normal cell on another normal cell 
• Adhesion of a cell with a foreign substance 
• Adhesion of a normal cell to a pathological cell 
• Adhesion of an adhesive to a biological substance.  
Leung and Robinson12described mucoadhesion as the 
interaction between a mucin surface and a synthetic or 
natural polymer. Mucoadhesion should not be confused with 
bioadhesion; in bioadhesion, the polymer is attached to the 
biological membrane and if the substrate is mucus 
membrane the term mucoadhesion is used. Dosage forms 
designed for mucoadhesive drug delivery should be small 
and flexible enough to be acceptable for patients and should 
not cause irritation. Other desired characteristics of a 
mucoadhesive dosage form include high 
drug loading capacity, controlled drug release (preferably 
unidirectional release), good mucoadhesive properties, 
smooth surface, tastelessness and convenient application. 
Erodible formulations can be beneficial because they do not 
require system retrieval at the end of desired dosing interval. 
A number of relevant mucoadhesive dosage forms have been 
developed for a variety of drugs. Several peptides, including 
thyrotropin-releasing hormone (TRH), insulin, octreotide, 
leuprolide, and oxytocin, have been delivered via the 
mucosal route, albeit with relatively low bioavailability (0.1–
5%),13 owing to their hydrophilicity and large molecular 
weight, as well as the inherent permeation and enzymatic 
barriers of the mucosa. The development of sustain release 
dosage form can achieve the aim of releasing the drug slowly 
for a long period but this is not sufficient to get sustained 
therapeutic effect. They may be cleared from the site of 
absorption before emptying the drug content. Instead, the 
mucoadhesive dosage form will serve both the purposes of 
sustain release and presence of dosage form at the site of 
absorption. In this regard, our review is high lighting various 
aspects of mucoadhesion, theories of mucoadhesion, 
mucoadhesive materials, factors affecting mucoadhesion, 
evaluating methods, mucoadhesive polymers and herbal 
drugs. 
Structure and composition of mucous and mucus 
layers 
The mucous membrane (mucosae) is characterized as a 
moist layer of connective tissue (thelamina propria), with an 
epithelial layer covered by mucus. According to the body 
cavity, these epithelia can be multilayered/stratified, such as 
in the vagina, cornea and esophagus, or single layered, like 
the small and large intestine. Moreover, this membrane has 
demonstrated 
a great ability for the absorption of active substances, since it 
is relatively permeable, enabling the quick absorption of 
drugs14-16. Mucus is a complex and viscous fluid synthesized 
by goblet cells. These glandular cells are present in every 
epithelium layer exposed to the external environment. 
Mucus is found as a gel layer which adheres to surfaces, as a 
soluble form, or suspended within the channels, creating a 
fully hydrated viscoelastic gel layer. This is composed of 
glycoproteins, including mucin, which is responsible for the 
gel structure and appearance, lipids, inorganic salts, proteins, 
mucopolysaccharides, IgA, lysozyme and 95% water. Mucin 
can be bound to the mucous membrane or secreted. The 
latter entangles and adhesively crosslinks reversibly in order 
to make up the viscoelastic, shear-thinning gel, by 
physiological mechanisms. Although mucin is the main factor 
responsible for the mucus gel properties, the viscoelastic 
behavior is also governed by water content, and lipids and 
ions from the mucus, being crucial for protection and 
lubrication. Furthermore, mucin (Figure 1) behaves as an 
anionic polyelectrolyte at neutral pH due to sialic acid, which 
is believed to be responsible for the bacteriostatic action 
observed in mucus6, 8,15,17,18. Mucus exhibits many functions 
such as protection and lubrication of the epithelium, in order 
to impair the absorption of microorganisms and other 
substances. In addition, mucus allows the passage of objects 
and preservation of the hydrated mucous layer, while other 
supplementary functions depend on the epithelium being 
covered14-17, 19. Although mucus has demonstrated numerous 
functions, it is a dynamic system, being continuously 
removed from the epithelial layer and can reduce the 
residence time, as well as decrease the drug delivery rate at 
the site of administration. Additionally, their properties, 
composition and thickness can be influenced by 
pathologies6,18. In this context, gastrointestinal, nasal, ocular, 
buccal, vaginal, rectal and periodontal areas are covered by a 
mucous membrane and can be employed for the 
administration of mucoadhesive drug delivery systems. 
According to the site of secretion, the pH and the thickness of 
the mucous layer are variable. The mucus pH in the eye is 
slightly basic, close to 7.8. However, for the lung and nasal 
cavity, the pH is 5.5-6.5. Also, the balance between the rate of 
mucus secretion and its rate of degradation and shedding 
regulate the thickness of the mucus layer. For the oral cavity, 
this is less than 1 μm, and it is 800 μm for the 
gastrointestinal tract6,14,15,18. In this sense, the strategic 
position of mucus in many diseases, such as inflammatory 
and infectious diseases and cancers, may provide a means for 
targeting the therapeutics more effectively using 
mucoadhesive drug delivery systems17. 
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Figure 1 Mucous membrane and the structures of the mucin molecule 
Mechanisms of mucoadhesion 
The mechanism of mucoadhesion is generally divided into 
two steps: the contact stage and the consolidation stage 
[Figure 2]. The first stage is characterized by the contact 
between the mucoadhesive and the mucus membrane, with 
spreading and swelling of the formulation, initiating its deep 
contact with the mucus layer20. In the consolidation step 
[Figure 2], the mucoadhesive materials are activated by the 
presence of moisture. Moisture plasticizes the system, 
allowing the mucoadhesive molecules to break free and to 
link up by weak van der Waals and hydrogen bonds. 
Essentially, there are two theories explaining the 
consolidation step: the diffusion theory and the dehydration 
theory. According to the diffusion theory, the mucoadhesive 
molecules and the glycoproteins of the mucus mutually 
interact by means of interpenetration of their chains and the 
building of secondary bonds. For this to take place, the 
mucoadhesive device has features favoring both chemical 
and mechanical interactions. For example, molecules with 
hydrogen bond building groups (–OH, –COOH), an anionic 
surface charge, high molecular weight, flexible chains and 
surface-active properties, which help in spreading 
throughout the mucus layer, can present mucoadhesive 
properties20. 
 
Figure 2 The process of contact and consolidation 
Mucoadhesion theories 
Mucoadhesion is a complex process and numerous theories 
have been proposed to explain the mechanisms involved. 
These theories include mechanical interlocking, 
electrostatic, diffusion interpenetration, adsorption and 
fracture processes. 
Wetting theory 
The wetting theory applies to liquid systems which present 
affinity to the surface in order to spread over it. This affinity 
can be found by using measuring techniques such as the 
contact angle. The general rule states that the lower the 
contact angle, the greater is the affinity [Figure 3]. The 
contact angle should be equal or close to zero to provide 
adequate spreadability. The spreadability coefficient, SAB, 
can be calculated from the difference between the surface 
energies γB and γA and the interfacial energy γAB, as 
indicated in the equation given below15. This theory explains 
the importance of contact angle and reduction of surface and 
interfacial energies to achieve good amount of 
mucoadhesion. 
SAB = γB ‒ γA ‒ γAB 
 
Figure 3 Influence of contact angle on mucoadhesion 
Diffusion theory 
Diffusion theory describes the interpenetration of both 
polymer and mucin chains to a sufficient depth to create a 
semi-permanent adhesive bond [Figure 4]. It is believed that 
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the adhesion force increases with the degree of penetration 
of the polymer chains. This penetration rate depends on the 
diffusion coefficient, flexibility and nature of the 
mucoadhesive chains, mobility and contact time. According 
to the literature, the depth of interpenetration required to 
produce an efficient bioadhesive bond lies in the range 0.2-
0.5 μm. This interpenetration depth of polymer and mucin 
chains can be estimated by the following equation: 
l = (tDb)½ 
Where t is the contact time and Db is the diffusion coefficient 
of the mucoadhesive material in the mucus. The adhesion 
strength for a polymer is reached when the depth of 
penetration is approximately equivalent to the polymer 
chain size. In order for diffusion to occur, it is important that 
the components involved have good mutual solubility, that 
is, both the bioadhesive and the mucus have similar chemical 
structures. The greater the structural similarity, the better is 
the mucoadhesive bond15. 
 
Figure 4 Secondary interaction between mucoadhesive 
device and of mucus 
Fracture theory 
This is perhaps the most used theory in studies on the 
mechanical measurement of mucoadhesion. It analyzes the 
force required to separate two surfaces after adhesion is 
established. This force, sm, is frequently calculated in tests of 
resistance to rupture by the ratio of the maximal detachment 
force, Fm, and the total surface area, A0, involved in the 
adhesive interaction  
Sm= Fm/ A0 
Since the fracture theory [Figure 5] is concerned only with 
the force required to separate the parts, it does not take into 
account the interpenetration or diffusion of polymer chains. 
Consequently, it is appropriate for use in the calculations for 
rigid or semi-rigid bioadhesive materials, in which the 
polymer chains do not penetrate into the mucus layer15, 20.  
 
Figure 5 Fractures occurring for mucoadhesion 
The electronic theory 
This theory describes adhesion occurring by means of 
electron transfer between the mucus and the mucoadhesive 
system, arising through differences in their electronic 
structures. The electron transfer between the mucus and the 
mucoadhesive results in the formation of double layer of 
electrical charges at the mucus and mucoadhesive interface. 
The net result of such a process is the formation of attractive 
forces within this double layer21. 
The adsorption theory 
In this instance, adhesion is the result of various surface 
interactions (primary and secondary bonding) between the 
adhesive polymer and mucus substrate. Primary bonds due 
to chemisorptions result in adhesion due to ionic, covalent 
and metallic bonding, which is generally undesirable due to 
their permanency22. Secondary bonds arise mainly due to 
van der Waals forces, hydrophobic interactions and 
hydrogen bonding. Whilst these interactions require less 
energy to “break”, they are the most prominent form of 
surface interaction in mucoadhesion processes as they have 
the advantage of being semi-permanent bonds23.  
Mechanical theory 
This theory considers the adhesion of mucoadhesive liquids 
systems (mucoadhesive liquids or particulate systems) 
which happens when the liquid fills the irregularities of a 
rough surface, since the adhesion is facilitated due to 
roughness on the substrate surface. These irregularities 
increase the area available to interact and improve the 
humectant characteristics. 
In this way, the mechanical theory has a close contact with 
the wetting theory, described previously, since both are 
adequate and complementary with regard to describing the 
adhesion of liquid systems. Moreover, with increased 
roughness there is higher viscoelasticity and plastic 
dissipation of the energy at the interface11. 
All these numerous theories should be considered as 
supplementary processes involved in the different stages of 
the mucus/substrate interaction, rather than individual and 
alternative theories. Each and every theory is equally 
important to describe the mucoadhesion process. There is a 
possibility that there will be initial wetting of the mucin, and 
then diffusion of the polymer into mucin layer, thus causing 
the fracture in the layers to effect the adhesion or electronic 
transfer or simple adsorption phenomenon that finally leads 
to the perfect mucoadhesion. The mechanism by which a 
mucoadhesive bond is formed will depend on the nature of 
the mucus membrane and mucoadhesive material, the type 
of formulation, the attachment process and the subsequent 
environment of the bond. It is apparent that a single 
mechanism for mucoadhesion proposed in many texts is 
unlikely for all the different occasions when adhesion occurs. 
Mucoadhesive polymers 
Different polymers have been explained by the researchers 
for the drug delivery. However, polymers having 
mucoadhesive nature should possess same specific 
characteristics and act as drug delivery system. An ideal 
mucoadhesive polymer has the following characteristics24,25: 
1. It must be loaded substantially by the active compound. 
2. It must swell in the aqueous biological environment of the 
site of absorption.  
3. It must interact with mucus or its components for 
adequate adhesion. 
4. It must allow controlled release of the active compound 
when swelled. 
5. It must be excreted unaltered or biologically degraded to 
inactive, nontoxic oligomers. 
6. It must possess sufficient quantities of hydrogen bonding 
chemical groups. 
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7. It must possess high molecular weight. 
8. It must possess high chain flexibility. 
9. It must have the surface tension that may induce 
spreading into mucous layer.  
Effect of polymer properties on mucoadhesive 
drug delivery system 
Different polymers exhibit different mucoadhesive 
properties depending on their physical and chemical 
strength. For example, a more flexible polymer exhibits 
higher degree of mucoadhesive property26. Mucoadhesive 
polymers possessing hydrophilic functional groups such as 
COOH, OH, NH2 and SO4H are more favorable candidates for 
the formulation of targeted drug delivery. These polymers 
bearing the desired functional group interact with mucus 
through physical entanglement as well as through chemical 
bonds resulting in formation of cross-linked network. For 
example, urea is a well-accepted hydrogen-bonding 
disruptor which decreases mucoadhesion of mucin/pectin 
samples. Other properties which may affect the 
mucoadhesive nature of the polymer include chain length, 
degree of hydration, degree of cross-linking, polymer 
concentration, charge, etc. (Table 1). 
 
Table 1 Effect of polymer properties on mucoadhesion27 
Properties Effect 
Functional group COOH, OH, NH2 , SO4 H groups favor mucoadhesion 
Molecular weight More is molecular weight (above 100,000) more is the bioadhesion 
Flexibility Higher is the flexibility of the polymer more is the diff usion and hence more mucoadhesion 
Chain length With decrease in chain length interpenetration increases 
Degree of hydration Excessive hydration leads to decreased mucoadhesion 
Degree of cross-linking Increased cross-linking decreased mucoadhesion 
Polymer concentration For semisolid: increase in concentration decrease mucoadhesion. 
For solid dosage form: increase in concentration increase mucoadhesion 
Charge Nonionic polymers posses less mucoadhesion than ionic and cationic polymers exhibits more 
mucoadhesion than anionic 
 
Polymers used for mucoadhesive drug delivery 
The rheology of the mucoadhesion is a typical topic and it 
deals with a number of forces, factors of the components, 
state of the material and its derived properties. Different 
polymers and their mucoadhesive strength are listed in 
Table 2. 
Based on the rheological aspects, we can categorize the 
mucoadhesive polymers into two broad categories: 
materials which undergo matrix formation or hydrogel 
formation by either a water swellable material or a water 
soluble material. These carriers are generally polymers and 
classified as given in Table 3. 
  
Table 2 Bioadhesive property of different polymers 
Polymer Bioadhesive property 
CMC sodium Excellent 
Carbopol Excellent 
Polycarbophil Excellent 
Tragacanth Excellent 
Sodium alginate Excellent 
HPMC Excellent 
Gum karaya Very good 
Gelatin Very good 
Guar gum Very good 
Pectin Good 
Acacia Good 
Chitosan Good 
Hydroxypropyl 
cellulose 
Good 
 
Table 3 Classification of bioadhesive polymers27 
Polymers Examples 
Hydrophilic polymers Methyl cellulose, Hydroxyethyl cellulose, HPMC, Na CMC, Carbomers 
Thiolated polymers Chitosan-iminothiolane, PAA-cysteine, PAA-homocysteine, Chitosan-thioglycolic acid, 
Chitosan- thioethylamidine, Alginate- cysteine, Poly (methacrylic acid)-cysteine and 
Sodium carboxymethylcellulose- cysteine 
Lectin-based polymers Lentil lectin, Peanut agglutinin, Ulex europaeus agglutinin 
Polyox WSR WSR N-10, WSR N-80, WSR N-205, WSR N-750. 
Novel polymers Tomato lectin, PAA-co-PEG, PSA 
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Hydrophilic polymers contain carboxylic group and possess 
excellent mucoadhesive properties. Matrices developed with 
these polymers swell when put into an aqueous media with 
subsequent dissolution of the matrix, for example, methyl 
cellulose, hydroxyethyl cellulose, hydroxypropyl 
methylcellulose (HPMC), sodium carboxymethyl cellulose, 
carbomers, chitosan and plant gums. Polyelectrolytes extend 
greater mucoadhesive property when compared with neutral 
polymers28. Anionic polyelectrolytes, for example, PAA and 
carboxymethyl cellulose have been extensively used for 
designing mucoadhesive delivery systems based on their 
ability to exhibit strong hydrogen bonding with the mucin 
present in the mucosal layer17. Chitosan, a cationic polymer, 
is widely used for its biodegradable and biocompatible 
properties and it undergoes electrostatic interactions with 
the negatively charged mucin chains thereby exhibiting 
mucoadhesive property29. The ionic polymers may be used to 
develop ionic complex with the counter-ionic drug molecules 
so as to have a drug delivery matrix exhibiting mucoadhesive 
property. Nonionic polymers, for example, poloxamer, HPMC, 
methyl cellulose, polyvinyl alcohol (PVA), and 
polyvinylpyrrolidone (PVP), have also been used for 
mucoadhesive properties28. The hydrophilic polymers form 
viscous solutions when dissolved in water and hence may 
also be used as viscosity modifying/enhancing agents in the 
development of liquid ocular delivery systems so as to 
increase the bioavailability of the active agents by reducing 
the drainage of the administered formulations28,30. 
Hydrogels: Hydrogels can be defined as three-dimensional 
cross-linked polymer chains which have the ability to hold 
water within its porous structure. The water-holding 
capacity of the hydrogels is mainly due to the presence of 
hydrophilic functional groups such as hydroxyl, amino and 
carboxyl groups. These include hydrogels prepared by 
thermal crosslinking of PAA and methyl cellulose31and 
hydrogels prepared by condensation reaction of PAA and 
sucrose32. In addition to the drug targeting, mucoadhesive 
hydrogel-based formulations improve the bioavailability of 
the poorly water-soluble drug.  
Novel polymers: With the advancement in the technology a 
large number of novel polymers have come into picture. 
Tomato lectin showed that it has binding selectivity to the 
small intestinal epithelium33. Shajaei and Xiaoling have 
designed and characterized a copolymer of PAA and 
polyethylene glycol (PEG) monoethyl ether mono 
methacrylate (PAA-co-PEG) for exhibiting optimal buccal 
adhesion34. Lele Hoff man (2000) investigated novel 
polymers of PAA complexed with PEGylated drug 
conjugate35. A new class of hydrophilic pressure sensitive 
adhesives (PSA) has been developed by Corium 
Technologies. A complex has been prepared by noncovalent 
hydrogenbonding cross-linking of a film forming hydrophilic 
polymer with a short chain plasticizer having reactive OH 
groups at chain ends. Similarly, Bogataj et al. (1999) 
prepared and studied mucoadhesive microspheres prepared 
using different polymers by solvent casting method for 
application in urinary bladder36. Chen and Langer (1998) 
investigated the benefit of thiolated polymers for the 
development of buccal drug delivery systems37. 
Some important bioadhesive polymers used in 
drug delivery 
Chitosan 
Chitosan is a biodegradable, nontoxic polymer obtained by 
deacetylation of the N-acetyl glucosamine units of chitin, 
generally by hydrolysis under alkali conditions at high 
temperature38. Due to its positive charge it shows ionic 
interaction with the negative charge of the sialic acid 
residues of mucus thus possessing very good bioadhesive 
properties. It is a biocompatible, pH-dependent cationic 
polymer, which is soluble in water up to pH 6.2. Basification 
of chitosan aqueous solutions above this pH leads to the 
formation of a hydrated gel-like precipitate. Chitosan being 
linear polymer provides greater polymer chain flexibility39. 
Many chitosan derivatives have been synthesized with 
improved mucoadhesion such as thiolated polymers, 
quaternized chitosan, fatty acid derivatives and different 
copolymers of chitosan40. Chitosan and its derivatives have 
been used in the formulation of various mucoadhesive 
controlled drug delivery systems.  
Carbopol 
Carbopol or carbomer are high molecular weight polymers of 
acrylic acid cross-linked with either allyl sucrose or allyl 
ethers of pentaerythritol. These contain 56% and 68% of 
carboxylic acid groups calculated on the dry bases41. These 
are used as suspending agent or viscosity increasing agent, 
dry and wet binder, as well as rate controlling agent in 
tablets, enzyme inhibitor of intestinal protease in peptide 
containing dosage form, etc. Carbomer is a pH-dependent 
polymer which stays in solution form at acidic pH but forms 
a low viscosity gel at alkaline pH. Carbopol offers the 
advantage of exhibiting excellent mucoadhesive properties in 
comparison with other polymers (e.g., cellulose derivatives 
and polyvinyl alcohol). Different mucoadhesive formulations 
containing carbopol have been developed and it was found 
that these demonstrated excellent mucoadhesive property 
and release the drug in controlled manner for a longer 
period of time. 
Alginate  
Alginates are random anionic, linear polymers consisting of 
varying ratios of glucuronic and manuronic acid units. Salts 
of alginate are formed when metal ion reacts with 
glucuronicor manuronic acid residue. Alginate has been used 
in many biomedical applications, including drug delivery 
systems, as they are biodegradable, biocompatible and 
mucoadhesive43. These delivery systems are formed when 
they are in monovalent, water-soluble state. Alginate salts 
undergo an aqueous sol-gel transformation to water-
insoluble salts due to the addition of divalent ions such as 
calcium, strontium and barium44. Mainly calcium alginate 
matrix is used for drug delivery systems including beads, 
gels, films, microparticles and sponges. Alginates with a high 
glucuronic acid contents form more rigid, porous gel due to 
their orientation within the egg-box structure and conversely 
gel with low glucuronic content are more randomly packed 
and less porous45.  
Sodium carboxymethyl cellulose (Na CMC) 
It is a low-cost, commercial, soluble and polyanionic 
polysaccharide derivative of cellulose that has been 
employed in medicine, as an emulsifying agent in 
pharmaceuticals and in cosmetics. The solution 
characteristics depend upon the average chain length and 
degree of polymerization. High and medium viscosity 
solutions of Na CMC possess thixotropic behavior46. The 
bioadhesive properties of the Na CMC are remarkable and it 
has been used in the development of various bioadhesive 
formulations such as matrix tablets, microspheres, buccal 
patches and nanoparticles. Going to the literature, a vast 
study has been carried out on Na CMC and various 
formulations have been prepared.  
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Hydroxypropyl methyl cellulose  
HPMC, a semisynthetic, inert, viscoelastic polymer used as an 
ophthalmic lubricant, emulsifi er, suspending agent, 
thickening agent and controlled-delivery component in oral 
medicaments, is found in a variety of commercial products. 
Also known as hypermellose, it is a thermosenstive polymer 
whose aqueous solution sets into gel when heated up to 
critical temperature47. It also shows good bioadhesive 
property due to its ability to exhibit strong hydrogen 
bonding with the mucin present in the mucosal layer. 
Various films, tablets and gels formulations have been 
formulated using HPMC as mucoadhesive polymer. The 
formulation shows very good mucoadhesion and provided 
sustained release.  
Factors affecting mucoadhesion 
Mucoadhesion may be affected by a number of factors, 
including 
1. Polymer related factors: 
i) Molecular weight 
ii) Concentration of active polymer 
iii) Flexibility of polymer chains 
iv) Spatial conformation 
v) Swelling 
vi) Hydrophilicity 
2. Environment related factors: 
i) pH of polymer - substrate interface 
ii) Applied strength 
iii) Initial contact time 
3. Physiological factors: 
i) Mucin turns over 
ii) Disease state 
Hydrophilicity 
Bioadhesive polymers possess numerous hydrophilic 
functional groups, such as hydroxyl and carboxyl. These 
groups allow hydrogen bonding with the substrate, swelling 
in aqueous media, thereby allowing maximal exposure of 
potential anchor sites. In addition, swollen polymers have 
the maximum distance between their chains leading to 
increased chain flexibility and efficient penetration of the 
substrate.  
Molecular weight 
The interpenetration of polymer molecules is favored by low 
molecular-weight polymers, whereas entanglements are 
favored at higher molecular weights. The optimum molecular 
weight for the maximum mucoadhesion depends on the type 
of polymer, with bioadhesive forces increasing with the 
molecular weight of the polymer up to 100,000. Beyond this 
level, there is no further gain48. 
Cross-linking and swelling 
Cross-link density is inversely proportional to the degree of 
swelling49. The lower the cross-link density, the higher the 
flexibility and hydration rate; the larger the surface area of 
the polymer, the better the mucoadhesion. To achieve a high 
degree of swelling, a lightly cross-linked polymer is favored. 
However, if too much moisture is present and the degree of 
swelling is too great, a slippy mucilage results and this can be 
easily removed from the substrate50. The mucoadhesion of 
cross-linked polymers can be enhanced by the inclusion in 
the formulation of adhesion promoters, such as free polymer 
chains and polymers grafted onto the preformed network51.  
Spatial conformation 
Besides molecular weight or chain length, spatial 
conformation of a polymer is also important. Despite a high 
molecular weight of 19,500,000 for dextrans, they have 
adhesive strength similar to that of polyethylene glycol 
(PEG), with a molecular weight of 200,000. The helical 
conformation of dextran may shield many adhesively active 
groups, primarily responsible for adhesion, unlike PEG 
polymers, which have a linear conformation52. 
pH 
The pH at the bioadhesive to substrate interface can 
influence the adhesion of bioadhesives possessing ionizable 
groups. Many bioadhesives used in drug delivery are 
polyanions possessing carboxylic acid functionalities. If the 
local pH is above the pK of the polymer, it will be largely 
ionized; if the pH is below the pK of the polymer, it will be 
largely unionized. The approximate pKa for the poly(acrylic 
acid) family of polymers is between 4 and 5. The maximum 
adhesive strength of these polymers is observed around pH 
4-5 and decreases gradually above a pH of 6. A systematic 
investigation of the mechanisms of mucoadhesion clearly 
showed that the protonated carboxyl groups, rather than the 
ionized carboxyl groups, react with mucin molecules, 
presumably by the simultaneous formation of numerous 
hydrogen bonds53. 
Concentration of active polymer 
Ahuja54 stated that there is an optimum concentration of 
polymer corresponding to the best mucoadhesion. In highly 
concentrated systems, beyond the optimum concentration 
the adhesive strength drops significantly. In concentrated 
solutions, the coiled molecules become solvent-poor and the 
chains available for interpenetration are not numerous. This 
result seems to be of interest only for more or less liquid 
mucoadhesive formulations. It was shown by Duchêne55 that, 
for solid dosage forms such as tablets, the higher the polymer 
concentration, the stronger the mucoadhesion.  
Drug/excipient concentration 
Drug/excipient concentration may influence the 
mucoadhesion. Blanco Fuente 56 studied the effect of 
propranolol hydrochloride to Carbopol® (a lightly cross-
linked poly(acrylic acid) polymer) hydrogels adhesion. 
Author demonstrated increased adhesion when water was 
limited in the system due to an increase in the elasticity, 
caused by the complex formation between drug and the 
polymer. While in the presence of large quantities of water, 
the complex precipitated out, leading to a slight decrease in 
the adhesive character. Increasing toluidine blue O (TBO) 
concentration in mucoadhesive patches based on Gantrez® 
(poly(methylvinylether/maleic acid) significantly increased 
mucoadhesion to porcine cheek tissue57This was attributed 
to increased internal cohesion within the patches due to 
electrostatic interactions between the cationic drug and 
anionic copolymer.  
Other factors affecting mucoadhesion 
Mucoadhesion may be affected by the initial force of 
application58. Higher forces lead to enhanced 
interpenetration and high bioadhesive strength59. In 
addition, the greater the initial contact time between 
bioadhesive and substrate, the greater the swelling and 
interpenetration of polymer   Physiological variables can also 
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affect mucoadhesion. The rate of mucus turnover can be 
affected by disease states and also by the presence of a 
bioadhesive device61. In addition, the nature of the surface 
presented to the bioadhesive formulation canvary 
significantly depending on the body site and the presence of 
local or systemic disease60. 
Evaluation of mucoadhesive drug delivery systems 
Mucoadhesive drug delivery systems can be evaluated by 
testing their adhesion strength. Various in vitro and in vivo 
tests (Figure 6) are available to determine the adhesion 
strength of the mucoadhesive polymers. 
  
 
Figure 6 Different methods for evaluation of mucoadhesive polymers 
 
Natural polymers 
The polymers within this category are soluble in water. 
Matrices developed with these polymers swell when they 
come in contact an aqueous media with subsequent 
dissolution of the matrix. The polyelectrolytes widen greater 
mucoadhesive property such as. poloxamer, hydroxypropyl 
methyl cellulose, methyl cellulose, poly (vinyl alcohol) and 
poly (vinyl pyrrolidone), have been used for mucoadhesive 
properties. The natural polysaccharides and its derivatives 
like chitosan, methyl cellulose, hyaluronic acid, hydroxy 
propyl methylcellulose, hydroxy propyl cellulose, Xanthan 
gum, gellan gum, guar gum, and Carrageenan have been 
utilized in development of ocular drug delivery systems. 
Cellulose and its derivates have been reported to have 
surface active property in addition to its film forming 
capability. Cellulose derivatives with lower surface acting 
property are normally preferred in ocular delivery systems 
as they cause reduced eye irritation. Cationic cellulose 
derivatives (e.g. cationic hydroxyethyl celluloses) have been 
used in conjunction with various anionic polymers for the 
development of sustained delivery systems62,63. 
List of natural polymers 
 Karya gum 
 Xanthan gum 
 Guar gum  
 Tragacanth  
 Pectin  
 Chitosan 
 Gum Arabic  
 Locust bean gum  
 Grewia gum 
 Bhara Gum  
 Mango Gum  
 Gelatin 
 Fenugreek gum  
 Tamarind gum 
Reported herbal patches 
Bhattacharjee et al prepared and characterizing 
mucoadhesive buccal patches with the incorporation of 
herbal extract.  Buccal patches were prepared with herbal 
(Neem) extract with two polymers such as methyl cellulose 
and hydroxy propyl methyl cellulose in a respective solvent 
such as ethanol with propylene glycol as the plasticizer64. 
Kanjani et al formulated transdermal patch incorporating 
herbal bioactive azadirachta indica. Transdermal patch was 
formulated by solvent casting method and was evaluated for 
organoleptic distinctiveness, stratification, weight 
consistency, flopping fortitude, dampness content, drug 
content and exterior morphology by scanning electron 
microscopy (SEM) 65. 
Saleem and Idris formulated and evaluate a Unani 
transdermal patch that could be used for antiemetic therapy. 
The incorporation of Unani ingredients, namely, Khardal 
(Brassica nigra), Zanjabeel (Zingiber officinale), Podina 
(Mentha arvensis), and Sirka (Vinegar) were envisaged. The 
TP was prepared by solvent evaporation technique and was 
evaluated for organoleptic characteristics and other 
physicochemical properties, such as thickness, weight 
uniformity, folding endurance, moisture content, drug 
content, and tolerability and acceptability of patch66. 
Das et al prepared and evaluate the transdermal patches of 
Cissus Quadrangularis extract by the solvent evaporation 
method using hydroxy propyl ethyl cellulose (HPMC E-15) in 
different concentrations. Di butyl phthalate and DMSO were 
used as plasticizers and permeation enhancer67. 
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Patel et al developed the transdermal patch of curcumin 
using polymer blends so that minimize the side effects and 
maximize the therapeutic efficacy68. 
Jasuja et al formulated matrix type transdermal patches of a 
potent anti atherosclerotic botanical Emblica officinalis on a 
mercury substrate and evaluated for physicochemical 
parameters like thickness, % flatness, weight variation, 
moisture uptake, moisture content, folding endurance, 
elongation and drug content values. Further, in vivo drug 
release was also observed by HPLC in rabbit serum69. 
Moghadamnia et al evaluated the efficacy of licorice 
bioadhesive hydrogel patches to control the pain and reduce 
the healing time of recurrent aphthous ulcer70. 
Hashemi et al developed Myrtus communis L. (Myrtle) 
containing oral patches and applied box-behnken design to 
evaluate the effect of polymers such as polyvinyl pyrrolidone 
(PVP), gelatin, methylcellulose (MC) and pectin. The patches 
properties such as tensile strength, folding endurance, 
swelling index, thickness, mucoadhesive strength and the 
pattern of myrtle release were evaluated as dependent 
variables. Then, the model was adjusted according to the 
best fitted equation with box behnken design71. 
Savula et al formulated and evaluate Nelumbo nucifera 
herbal patches. Nelumbo nucifera Gaertn (Nymphaeaceae), a 
perennial aquatic plant, has been used as a medicinal herb in 
China and India72. 
Bhutkar formulated and evaluate mucoadhesive buccal 
patch for systemic drug delivery of drug like flavonoid which 
is isolated from the leaves of Psidium guajava in which 
system avoid first pass effect of hepatic metabolism73. 
Suksaeree et al studied the preparation, physicochemical 
characterization, and in vitro characteristic of Zingiber 
cassumunar blended patches. The Z. cassumunar blended 
patches incorporating Z. cassumunar Roxb also known as 
Plai were prepared from chitosan and polyvinyl alcohol with 
glycerin as plasticizer74. 
Conclusion  
Today, drug delivery systems designed with the aim to 
improve patient compliance and convenience is more 
important than ever. Therefore huge work is going on to 
develop novel dosage forms to satisfy increased patient 
demands of more convenient dosage forms. This overview 
about the mucoadhesive dosage forms might be a useful tool 
for the efficient design of novel mucoadhesive drug delivery 
systems. Mucoadhesive drug delivery systems have 
applications from different angles, including development of 
novel mucoadhesive, design of the device, mechanisms of 
mucoadhesion and permeation enhancement. With the 
influx of a large number of new drug molecules due to drug 
discovery, mucoadhesive drug delivery will play an even 
more important role in delivering these molecules. The 
mucoadhesive dosage forms offer prolonged contact at the 
site of administration, low enzymatic activity, and patient 
compliance. However, these novel mucoadhesive 
formulations require much more work, to deliver clinically 
for the treatment of both topical and systemic diseases. 
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